Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany.

Krasnianski A, Bohling GT, Heinemann U, Varges D, Meissner B, Schulz-Schaeffer WJ, Reif A, Zerr I.

J Alzheimers Dis. 2017;59(1):329-337. doi: 10.3233/JAD-161129.

PMID:
28598840
2.

Doxycycline in early CJD: a double-blinded randomised phase II and observational study.

Varges D, Manthey H, Heinemann U, Ponto C, Schmitz M, Schulz-Schaeffer WJ, Krasnianski A, Breithaupt M, Fincke F, Kramer K, Friede T, Zerr I.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):119-125. doi: 10.1136/jnnp-2016-313541. Epub 2016 Nov 2.

3.

Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.

Gmitterová K, Heinemann U, Krasnianski A, Gawinecka J, Zerr I.

Eur J Neurol. 2016 Jun;23(6):1126-33. doi: 10.1111/ene.12991. Epub 2016 Mar 31.

PMID:
27029507
4.

Clinical findings and diagnosis in genetic prion diseases in Germany.

Krasnianski A, Heinemann U, Ponto C, Kortt J, Kallenberg K, Varges D, Schulz-Schaeffer WJ, Kretzschmar HA, Zerr I.

Eur J Epidemiol. 2016 Feb;31(2):187-96. doi: 10.1007/s10654-015-0049-y. Epub 2015 Jun 16.

PMID:
26076917
5.

Psychiatric symptoms in patients with sporadic Creutzfeldt-Jakob disease in Germany.

Krasnianski A, Bohling GT, Harden M, Zerr I.

J Clin Psychiatry. 2015 Sep;76(9):1209-15. doi: 10.4088/JCP.13m08915.

PMID:
25938948
6.

First symptom and initial diagnosis in sporadic CJD patients in Germany.

Krasnianski A, Kaune J, Jung K, Kretzschmar HA, Zerr I.

J Neurol. 2014 Sep;261(9):1811-7. doi: 10.1007/s00415-014-7410-z. Epub 2014 Jul 15.

PMID:
25022936
7.

Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study.

Schnell T, Koethe D, Krasnianski A, Gairing S, Schnell K, Daumann J, Gouzoulis-Mayfrank E.

Am J Addict. 2014 May-Jun;23(3):308-12. doi: 10.1111/j.1521-0391.2014.12126.x. Epub 2014 Mar 15.

PMID:
24628830
8.

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.

Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F.

Lancet Neurol. 2014 Feb;13(2):150-8. doi: 10.1016/S1474-4422(13)70307-7. Epub 2014 Jan 8.

PMID:
24411709
9.

A proposal of new diagnostic pathway for fatal familial insomnia.

Krasnianski A, Sanchez Juan P, Ponto C, Bartl M, Heinemann U, Varges D, Schulz-Schaeffer WJ, Kretzschmar HA, Zerr I.

J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):654-9. doi: 10.1136/jnnp-2013-305978. Epub 2013 Nov 18.

10.

Valproate-induced hyperammonemic encephalopathy followed by benzodiazepine withdrawal in a patient with schizoaffective disorder: a differential diagnosis.

Sarlon J, Hess E, Krasnianski A.

J Neuropsychiatry Clin Neurosci. 2013 Summer;25(3):E69-70. doi: 10.1176/appi.neuropsych.12090218. No abstract available.

PMID:
24026753
11.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.

Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I.

J Alzheimers Dis. 2011;23(4):717-26. doi: 10.3233/JAD-2010-101527.

PMID:
21157024
12.

Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.

Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I.

J Alzheimers Dis. 2009;17(4):863-73. doi: 10.3233/JAD-2009-1110.

13.

MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Meissner B, Kallenberg K, Sanchez-Juan P, Ramljak S, Krasnianski A, Heinemann U, Eigenbrod S, Gelpi E, Barsic B, Kretzschmar HA, Schulz-Schaeffer WJ, Knauth M, Zerr I.

J Neurol. 2009 Mar;256(3):355-63. doi: 10.1007/s00415-009-0026-z. Epub 2009 Jan 23.

PMID:
19159063
14.

Brain biopsy in patients with suspected Creutzfeldt-Jakob disease.

Heinemann U, Krasnianski A, Meissner B, Kallenberg K, Kretzschmar HA, Schulz-Schaeffer W, Zerr I.

J Neurosurg. 2008 Oct;109(4):735-41. doi: 10.3171/JNS/2008/109/10/0735.

PMID:
18826363
15.

MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study.

Krasnianski A, Kallenberg K, Collie DA, Meissner B, Schulz-Schaeffer WJ, Heinemann U, Varges D, Summers DM, Kretzschmar HA, Talbot T, Will RG, Zerr I.

Eur J Neurol. 2008 Aug;15(8):762-71. doi: 10.1111/j.1468-1331.2008.02209.x.

PMID:
18684308
16.

Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease.

Meissner B, Kallenberg K, Sanchez-Juan P, Krasnianski A, Heinemann U, Varges D, Knauth M, Zerr I.

AJNR Am J Neuroradiol. 2008 Sep;29(8):1519-24. doi: 10.3174/ajnr.A1122. Epub 2008 Jul 3.

17.

Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.

Gloeckner SF, Meyne F, Wagner F, Heinemann U, Krasnianski A, Meissner B, Zerr I.

J Alzheimers Dis. 2008 May;14(1):17-25.

PMID:
18525124
18.

Novel PRNP mutation in a patient with a slow progressive dementia syndrome.

Heinemann U, Krasnianski A, Meissner B, Grasbon-Frodl EM, Kretzschmar HA, Zerr I.

Med Sci Monit. 2008 May;14(5):CS41-43.

PMID:
18443555
19.

Fatal familial insomnia: Clinical features and early identification.

Krasnianski A, Bartl M, Sanchez Juan PJ, Heinemann U, Meissner B, Varges D, Schulze-Sturm U, Kretzschmar HA, Schulz-Schaeffer WJ, Zerr I.

Ann Neurol. 2008 May;63(5):658-61. doi: 10.1002/ana.21358.

PMID:
18360821
20.

14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes.

Gmitterová K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I.

Neurobiol Aging. 2009 Nov;30(11):1842-50. doi: 10.1016/j.neurobiolaging.2008.01.007. Epub 2008 Mar 6.

PMID:
18328602
21.

ApoE distribution and family history in genetic prion diseases in Germany.

Krasnianski A, von Ahsen N, Heinemann U, Meissner B, Kretzschmar HA, Armstrong VW, Zerr I.

J Mol Neurosci. 2008;34(1):45-50. Epub 2007 Sep 11.

PMID:
18157657
22.

Increased frequency of positive family history of dementia in sporadic CJD.

Krasnianski A, von Ahsen N, Heinemann U, Meissner B, Schulz-Schaeffer WJ, Kretzschmar HA, Armstrong VW, Zerr I.

Neurobiol Aging. 2009 Apr;30(4):615-21. Epub 2007 Sep 5.

PMID:
17822808
23.

Molecular subtype-specific clinical diagnosis of prion diseases.

Heinemann U, Krasnianski A, Meissner B, Gloeckner SF, Kretzschmar HA, Zerr I.

Vet Microbiol. 2007 Aug 31;123(4):328-35. Epub 2007 Apr 7.

PMID:
17513070
24.

Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.

Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I.

Brain. 2007 May;130(Pt 5):1350-9.

PMID:
17472986
25.

Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.

Sanchez-Juan P, Sánchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrová E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichová D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn CM, Zerr I.

J Neurol. 2007 Jul;254(7):901-6. Epub 2007 Mar 25.

26.

Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?

Boesenberg-Grosse C, Schulz-Schaeffer WJ, Bodemer M, Ciesielczyk B, Meissner B, Krasnianski A, Bartl M, Heinemann U, Varges D, Eigenbrod S, Kretzschmar HA, Green A, Zerr I.

BMC Neurol. 2006 Sep 21;6:35.

27.

Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.

Krasnianski A, Meissner B, Heinemann U, Zerr I.

Folia Neuropathol. 2004;42 Suppl B:24-38. Review.

PMID:
16903140
28.

Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.

Krasnianski A, Meissner B, Schulz-Schaeffer W, Kallenberg K, Bartl M, Heinemann U, Varges D, Kretzschmar HA, Zerr I.

Arch Neurol. 2006 Jun;63(6):876-80.

PMID:
16769870
29.

Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD.

Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, Meissner B, Collie DA, Roeber S, Bartl M, Heinemann U, Varges D, Kretzschmar HA, Zerr I.

Brain. 2006 Sep;129(Pt 9):2288-96. Epub 2006 May 23.

PMID:
16720682
30.

Reply to 'Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies--a comment'.

Krasnianski A, Deschauer M, Krasnianski M, Zierz S.

Brain. 2006 Mar;129(Pt 3):E41. No abstract available.

PMID:
16477084
31.

Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type.

Meissner B, Westner IM, Kallenberg K, Krasnianski A, Bartl M, Varges D, Bösenberg C, Kretzschmar HA, Knauth M, Schulz-Schaeffer WJ, Zerr I.

Neurology. 2005 Nov 22;65(10):1544-50. Epub 2005 Oct 12.

PMID:
16221949
32.

Clinical course in young patients with sporadic Creutzfeldt-Jakob disease.

Boesenberg C, Schulz-Schaeffer WJ, Meissner B, Kallenberg K, Bartl M, Heinemann U, Krasnianski A, Stoeck K, Varges D, Windl O, Kretzschmar HA, Zerr I.

Ann Neurol. 2005 Oct;58(4):533-43.

PMID:
16037975
33.

Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies.

Krasnianski A, Deschauer M, Neudecker S, Gellerich FN, Müller T, Schoser BG, Krasnianski M, Zierz S.

Brain. 2005 Aug;128(Pt 8):1870-6. Epub 2005 May 18.

PMID:
15901649
34.

Supplemental Content

Loading ...
Support Center